Uses of didemnins as immunomodulating agents

Glynn Faircloth (Inventor), Kenneth L. Rinehart (Inventor)

Research output: Patent


The present invention is based upon the immunomodulatory activity of synthetic and semi-synthetic didemnin compounds. It has surprisingly been discovered that certain didemnin compounds possess unexpectedly high immunomodulation activity, and thus will be useful for modulating or regulating immunological functions in warm blooded animals. From the data provided herein it is believed that the physician will be able to determine the appropriate dosage of the immunosuppressant didemnins of the present invention. The actual dosage to be administered depends, inter alia, on the animal species to be treated, the subject animal's size, and the capacity of the subject to utilize the particular didemnin compound administered. Accordingly, the actual amounts of any didemnin compound required to be administered depend on the judgment of the practitioner.
Original languageEnglish (US)
U.S. patent number6156724
Filing date7/7/98
StatePublished - Dec 5 2000


Dive into the research topics of 'Uses of didemnins as immunomodulating agents'. Together they form a unique fingerprint.

Cite this